EUVIMEDEUVIMED entdecken
Crossref

Features of complex medicamental therapy in patients with silent myocardial ischemia of high risk after myocardial infarction

Tetiana V Merhel, Tetiana V Naluzhna, Khrystyna V Levandovska

Wiadomości Lekarskie · 2025

DOI: 10.36740/wlek/201337 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Wiadomości Lekarskie, 2025. Verfasst von Tetiana V Merhel und 2 weiteren Autor:innen. Beteiligte Einrichtung: IVANO-FRANKIVSK NATIONAL MEDICAL UNIVERSITY, IVANO-FRANKIVSK, UKRAINE. Hauptthemen laut MEDLINE: Myocardial Infarction, Myocardial Ischemia, Enalapril, Amlodipine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To determine the peculiarities of the course of silent myocardial ischemia (SMI) in patients with post-infarction cardiosclerosis depending on the risk factors (RFs); to reveal the interdependence between the presence of pathological turbulence of the heart rhythm and the peculiarities of the course of SMI in patients with post-infarction cardiosclerosis and the effectiveness of treatment applying S-amlodipine and enalapril in complex therapy. Materials and Methods: There were observed 154 patients with SMI with a history of myocardial infarction, having received anti-anginal therapy. The diagnosis of SMI was made according to Holter ECG monitoring data. Among the additional indices of the severity of the patient’s condition, the maximum value of the ST segment deviation amplitude was evaluated.

Results

It was determined that in patients with SMI with post-infarction cardiosclerosis, there is a positive correlation between the presence of RFs and Holter ECG monitoring indices, in particular, the average daily values of the number of ischemic episodes, the total daily duration of ST segment depression and the average duration of one ischemic episode. Enalapril and S-amlodipine are the effective means of pharmacotherapy in the SMI.

Conclusions

The silent myocardial ischemia, which is associated with the presence of such Rfs as arterial hypertension, diabetes melitus, dyslipidemia or their combination, is characterized by a severe course of the disease, which is manifested by a worsening of the clinical condition, a decrease in tolerance to physical exertion, significant changes in hemodynamics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionMyocardial IschemiaEnalaprilAmlodipineHumansMaleFemaleMiddle AgedElectrocardiography, AmbulatoryAgedRisk Factors

Stichwörter der Autor:innen

post-infarction cardiosclerosisheart rate turbulanceanti-ischemic therapyheart rate variability

Substanzen

EnalaprilAmlodipine

Autor:innen und Institutionen

  • IVANO-FRANKIVSK NATIONAL MEDICAL UNIVERSITY, IVANO-FRANKIVSK, UKRAINE.

Zitieren

APA

Merhel, T. V., Naluzhna, T. V., & Levandovska, K. V. (2025). Features of complex medicamental therapy in patients with silent myocardial ischemia of high risk after myocardial infarction. Wiadomości Lekarskie. https://doi.org/10.36740/wlek/201337

Vancouver

Merhel TV, Naluzhna TV, Levandovska KV. Features of complex medicamental therapy in patients with silent myocardial ischemia of high risk after myocardial infarction. Wiadomości Lekarskie. 2025. doi:10.36740/wlek/201337

BibTeX
@article{Merhel2025,
  author = {Merhel, Tetiana V and Naluzhna, Tetiana V and Levandovska, Khrystyna V},
  title = {Features of complex medicamental therapy in patients with silent myocardial ischemia of high risk after myocardial infarction},
  journal = {Wiadomości Lekarskie},
  year = {2025},
  doi = {10.36740/wlek/201337}
}
Kostenlos starten →